Terms: = Breast cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Treatment
76 results:
1. pDNA-tachyplesin treatment stimulates the immune system and increases the probability of apoptosis in MC4-L2 tumor cells.
Mahmoudi-Filabadi F; Doosti A
Amino Acids; 2024 May; 56(1):34. PubMed ID: 38691208
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implication of novel immune-related signature in breast cancer.
Chen B; Wu H; Fang Y; Huang G; Guo C; Chen C; He L; Chen Z; Hou X; Li C; Wu J
Medicine (Baltimore); 2024 Feb; 103(6):e37065. PubMed ID: 38335435
[TBL] [Abstract] [Full Text] [Related]
3. "Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.".
Pala L; Sala I; Pagan E; De Pas T; Zattarin E; Catania C; Cocorocchio E; Rossi G; Laszlo D; Ceresoli G; Canzian J; Valenzi E; Bagnardi V; Conforti F
Breast; 2024 Feb; 73():103672. PubMed ID: 38244459
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of everolimus-based therapy in advanced triple-positive breast cancer: Experience from three cancer centers in China.
Tan Y; Jiang H; Ma F; Wang J; Zhang P; Li Q; Tian X; Xu B; Zhao W; Fan Y
Thorac Cancer; 2023 Dec; 14(34):3397-3405. PubMed ID: 37936567
[TBL] [Abstract] [Full Text] [Related]
5. An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response.
Dioken DN; Ozgul I; Yilmazbilek I; Yakicier MC; Karaca E; Erson-Bensan AE
Cancer Immunol Immunother; 2023 Dec; 72(12):4065-4075. PubMed ID: 37768345
[TBL] [Abstract] [Full Text] [Related]
6. Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC; Pepa M; Zaffaroni M; Vincini MG; Luraschi R; Vigorito S; Morra A; Dicuonzo S; Mazzola GC; Gerardi MA; Zerella MA; Cante D; Petrucci E; Borzì G; Marrocco M; Chieregato M; Iadanza L; Lobefalo F; Valenti M; Cavallo A; Russo S; Guernieri M; Malatesta T; Meaglia I; Liotta M; Palumbo I; Marcantonini M; Mezzenga E; Falivene S; Arrichiello C; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Giannitto C; Ciabattoni A; Meattini I; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA
Tumori; 2023 Dec; 109(6):570-575. PubMed ID: 37688419
[TBL] [Abstract] [Full Text] [Related]
7. Anticancer activity of Ni(II) and Zn(II) complexes based on new unsymmetrical salophen-type ligands: synthesis, characterization and single-crystal X-ray diffraction.
Villaman D; Vega A; Santa Maria de la Parra L; León IE; Levín P; Toro PM
Dalton Trans; 2023 Aug; 52(31):10855-10868. PubMed ID: 37486008
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.
Reinisch M; Bruzas S; Gluz O; Ataseven B; Schmid P; Cortés J; Blohmer JU; Shenoy S; Dyson MH; Dittmer-Grabowski C; Chiari O; Harrach H; Gebauer D; Traut A; Kuemmel S
Mol Oncol; 2023 Jun; 17(6):1060-1075. PubMed ID: 37057719
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and breast cancer Cells.
Devi S; Gründemann C; Huber R; Kowarschik S
Complement Med Res; 2023; 30(5):386-392. PubMed ID: 36927644
[TBL] [Abstract] [Full Text] [Related]
10. Variable Intrinsic Expression of Immunoregulatory Biomarkers in breast cancer Cell Lines, Mammospheres, and Co-Cultures.
Montoyo-Pujol YG; García-Escolano M; Ponce JJ; Delgado-García S; Martín TA; Ballester H; Castellón-Molla E; Martínez-Peinado P; Pascual-García S; Sempere-Ortells JM; Peiró G
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901916
[TBL] [Abstract] [Full Text] [Related]
11. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.
Chintala NK; Choe JK; McGee E; Bellis R; Saini JK; Banerjee S; Moreira AL; Zauderer MG; Adusumilli PS; Rusch VW
Front Immunol; 2023; 14():1112960. PubMed ID: 36875061
[TBL] [Abstract] [Full Text] [Related]
12. High PD-L2 Predicts Early Recurrence of ER-Positive breast cancer.
Chervoneva I; Peck AR; Sun Y; Yi M; Udhane SS; Langenheim JF; Girondo MA; Jorns JM; Chaudhary LN; Kamaraju S; Bergom C; Flister MJ; Hooke JA; Kovatich AJ; Shriver CD; Hu H; Palazzo JP; Bibbo M; Hyslop T; Nevalainen MT; Pestell RG; Fuchs SY; Mitchell EP; Rui H
JCO Precis Oncol; 2023 Jan; 7():e2100498. PubMed ID: 36652667
[TBL] [Abstract] [Full Text] [Related]
13. PDJ amplicon in triple negative breast cancer.
Roesler AS; Malasi S; Koslosky L; Hartmayer P; Naab TJ; Carter JM; Zahrieh D; Hillman D; Leon-Ferre RA; Couch FJ; Goetz MP; Anderson KS; Pockaj BA; Barrett MT
Sci Rep; 2023 Jan; 13(1):618. PubMed ID: 36635351
[TBL] [Abstract] [Full Text] [Related]
14. Pucotenlimab: First Approval.
Dhillon S
Drugs; 2022 Oct; 82(15):1557-1564. PubMed ID: 36308601
[TBL] [Abstract] [Full Text] [Related]
15. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in breast Tumor-bearing Mice.
Rostamzadeh D; Haghshenas MR; Samadi M; Mojtahedi Z; Babaloo Z; Ghaderi A
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):287-299. PubMed ID: 35822679
[TBL] [Abstract] [Full Text] [Related]
16. Implications of PD-1, Tim-3, and TIGIT Expression for cancer Immunity and Pancreatic cancer Prognosis.
Nakayama C; Tanoue K; Idichi T; Shimomura H; Kita Y; Hozaka Y; Shinden Y; Matsushita D; Nakajo A; Arigami T; Mataki Y; Kurahara H; Ohtsuka T
Anticancer Res; 2022 Jul; 42(7):3373-3380. PubMed ID: 35790289
[TBL] [Abstract] [Full Text] [Related]
17. treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment.
Yang ZY; Jiang CW; Zhang WL; Sun G
J Transl Med; 2022 Jun; 20(1):276. PubMed ID: 35717238
[TBL] [Abstract] [Full Text] [Related]
18. Correlation Analysis between Tamoxifen and Lumbar Intervertebral Disc Degeneration: A Retrospective Case-Control Study.
Li X; Zhao R; Rudd S; Ding W; Yang S
Pain Res Manag; 2022; 2022():3330260. PubMed ID: 35685675
[TBL] [Abstract] [Full Text] [Related]
19. DNA-Functionalized Liposomes
Zhang N; Shu G; Qiao E; Xu X; Shen L; Lu C; Chen W; Fang S; Yang Y; Song J; Zhao Z; Tu J; Xu M; Chen M; Du Y; Ji J
ACS Appl Mater Interfaces; 2022 May; 14(18):20603-20615. PubMed ID: 35476429
[TBL] [Abstract] [Full Text] [Related]
20. Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cells.
Murayama MA; Takada E; Takai K; Arimitsu N; Shimizu J; Suzuki T; Suzuki N
PLoS One; 2022; 17(1):e0260838. PubMed ID: 35085258
[TBL] [Abstract] [Full Text] [Related]
[Next]
